Justin Walsh
Stock Analyst at JonesTrading
(4.76)
# 602
Out of 4,468 analysts
380
Total ratings
40.6%
Success rate
22.3%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Reiterated: Buy | $44 | $24.78 | +77.56% | 19 | Jun 26, 2026 | |
| ATAI AtaiBeckley | Maintained: Buy | $16 | $5.19 | +208.29% | 7 | Jun 25, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $61 → $74 | $44.19 | +67.46% | 6 | Jun 23, 2026 | |
| BLRX BioLineRx | Reiterated: Buy | $12 | $3.29 | +265.30% | 10 | Jun 2, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $441 | $318.52 | +38.45% | 11 | Jun 2, 2026 | |
| VNRX VolitionRx | Reiterated: Buy | $60 → $24 | $1.40 | +1,614.29% | 5 | May 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $1.90 | +478.95% | 8 | May 18, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $6.10 | +391.80% | 14 | May 15, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $0.9201 | +769.47% | 4 | May 15, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 | $3.63 | +395.87% | 34 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.02 | +165.34% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.69 | +134.54% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.40 | +212.50% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $109.89 | - | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $38.97 | +28.30% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.981 | +817.43% | 32 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.37 | +586.50% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.468 | +327.35% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.59 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $97.79 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.98 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.02 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.87 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $1.45 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.3466 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $42.74 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.4718 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.27 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $0.39 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $37.50 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.18 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.64 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $21.82 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.248 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.36 | n/a | 1 | Feb 17, 2021 |
Alto Neuroscience
Jun 26, 2026
Reiterated: Buy
Price Target: $44
Current: $24.78
Upside: +77.56%
AtaiBeckley
Jun 25, 2026
Maintained: Buy
Price Target: $16
Current: $5.19
Upside: +208.29%
Definium Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $61 → $74
Current: $44.19
Upside: +67.46%
BioLineRx
Jun 2, 2026
Reiterated: Buy
Price Target: $12
Current: $3.29
Upside: +265.30%
Praxis Precision Medicines
Jun 2, 2026
Reiterated: Buy
Price Target: $441
Current: $318.52
Upside: +38.45%
VolitionRx
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $1.40
Upside: +1,614.29%
Serina Therapeutics
May 18, 2026
Reiterated: Buy
Price Target: $11
Current: $1.90
Upside: +478.95%
Clene
May 15, 2026
Reiterated: Buy
Price Target: $30
Current: $6.10
Upside: +391.80%
RenovoRx
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.9201
Upside: +769.47%
Perspective Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $18
Current: $3.63
Upside: +395.87%
May 13, 2026
Reiterated: Buy
Price Target: $8
Current: $3.02
Upside: +165.34%
May 13, 2026
Reiterated: Buy
Price Target: $11
Current: $4.69
Upside: +134.54%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $6.40
Upside: +212.50%
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $109.89
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $50
Current: $38.97
Upside: +28.30%
Apr 2, 2026
Reiterated: Buy
Price Target: $9
Current: $0.981
Upside: +817.43%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $4.37
Upside: +586.50%
Mar 11, 2026
Reiterated: Buy
Price Target: $2
Current: $0.468
Upside: +327.35%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $20.59
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $97.79
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $3.98
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.02
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $3.87
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $1.45
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $0.3466
Upside: n/a
May 19, 2022
Maintained: Buy
Price Target: $16 → $20
Current: $42.74
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $0.4718
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $2.27
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $7 → $6
Current: $0.39
Upside: n/a
Apr 7, 2022
Maintained: Buy
Price Target: $10
Current: $37.50
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $5.18
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $5.64
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $21.82
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $0.248
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $1.36
Upside: n/a